These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 11279719

  • 1. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; (1):CD001516. PubMed ID: 11279718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cabergoline for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; 2001(1):CD001518. PubMed ID: 11279720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pramipexole for levodopa-induced complications in Parkinson's disease.
    Clarke C E, Speller J M, Clarke J A.
    Cochrane Database Syst Rev; 2000; 2000(3):CD002261. PubMed ID: 10908540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pergolide for levodopa-induced complications in Parkinson's disease.
    Clarke C E, Speller J M.
    Cochrane Database Syst Rev; 2000; (2):CD000235. PubMed ID: 10796704
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C, van Hilten JJ.
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [Abstract] [Full Text] [Related]

  • 15. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 16. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.
    Deane KH, Spieker S, Clarke CE.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD004554. PubMed ID: 15495119
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
    Stowe R, Ives N, Clarke CE, Deane K, van Hilten, Wheatley K, Gray R, Handley K, Furmston A.
    Cochrane Database Syst Rev; 2010 Jul 07; (7):CD007166. PubMed ID: 20614454
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
    Brunt ER, Brooks DJ, Korczyn AD, Montastruc JL, Stocchi F, 043 Study Group.
    J Neural Transm (Vienna); 2002 Apr 07; 109(4):489-502. PubMed ID: 11956968
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.